170 related articles for article (PubMed ID: 35163997)
1. Enhancing Ocular Bioavailability of Ciprofloxacin Using Colloidal Lipid-Based Carrier for the Management of Post-Surgical Infection.
Al-Joufi FA; Salem-Bekhit MM; Taha EI; Ibrahim MA; Muharram MM; Alshehri S; Ghoneim MM; Shakeel F
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163997
[TBL] [Abstract][Full Text] [Related]
2. Anti-microbial Effect and in Vivo Ocular Delivery of Ciprofloxacin-loaded Liposome through Rabbit's Eye.
Feghhi M; Sharif Makhmalzadeh B; Farrahi F; Akmali M; Hasanvand N
Curr Eye Res; 2020 Oct; 45(10):1245-1251. PubMed ID: 32045531
[No Abstract] [Full Text] [Related]
3. Design of liposomal colloidal systems for ocular delivery of ciprofloxacin.
Taha EI; El-Anazi MH; El-Bagory IM; Bayomi MA
Saudi Pharm J; 2014 Jul; 22(3):231-9. PubMed ID: 25061409
[TBL] [Abstract][Full Text] [Related]
4. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Abdelbary G
Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies.
Charoo NA; Kohli K; Ali A; Anwer A
Drug Dev Ind Pharm; 2003 Feb; 29(2):215-21. PubMed ID: 12648018
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-induced Synergy for Extended Antimicrobial Potency and Enhanced In Vitro Drug Release of Free Base Ciprofloxacin Nanoplexes.
Abioye A; Sanyaolu A; Dudzinska P; Adepoju-Bello AA; Coker HAB
Pharm Nanotechnol; 2020; 8(1):33-53. PubMed ID: 31642799
[TBL] [Abstract][Full Text] [Related]
7. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G
Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119
[TBL] [Abstract][Full Text] [Related]
9. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin Loaded Nanostructured Lipid Carriers Incorporated into In-Situ Gels to Improve Management of Bacterial Endophthalmitis.
Youssef A; Dudhipala N; Majumdar S
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32575524
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
13. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
Babizhayev MA
Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.
Khalil RM; Abdelbary GA; Basha M; Awad GE; El-Hashemy HA
J Liposome Res; 2017 Jun; 27(2):118-129. PubMed ID: 27079800
[TBL] [Abstract][Full Text] [Related]
15. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
AAPS PharmSciTech; 2013 Jun; 14(2):782-93. PubMed ID: 23615773
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
Mehanna MM; Elmaradny HA; Samaha MW
Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
[TBL] [Abstract][Full Text] [Related]
17. Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
Charoo NA; Kohli K; Ali A
J Pharm Sci; 2003 Feb; 92(2):407-13. PubMed ID: 12532390
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of intraocular absorption and drug metabolism of N-acetylcarnosine lubricant eye drops: drug interaction with sight threatening lipid peroxides in the treatment for age-related eye diseases.
Babizhayev MA
Drug Metabol Drug Interact; 2009; 24(2-4):275-323. PubMed ID: 20408504
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro/in vivo evaluations of novel ocular micelle formulations of hesperetin with glycyrrhizin as a nanocarrier.
Zhang F; Chen H; Lan J; Song K; Wu X
Exp Eye Res; 2021 Jan; 202():108313. PubMed ID: 33080302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]